Investigational New Drugs,volume 28,issue 4  (08-2014)

Period of time: 2014年4期

Publisher: Springer Publishing Company

Founded in: 1983

Total resources: 32

ISSN: 0167-6997

Subject: R9 Pharmacy

Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Investigational New Drugs,volume 28,issue 4

Menu

Development and pharmacologic characterization of deoxybromophospha sugar derivatives with antileukemic activity

By Nakamura Satoki,Yamashita Mitsuji,Yokota Daisuke,Hirano Isao,Ono Takaaki,Fujie Michio,Shibata Kiyoshi,Niimi Taishi,Suyama Takuya,Maddali Kasthuraiah,Asai Kazuhide,Yamashita Junko,Iguchi Yukiko,Ohnishi Kazunori in (2010)

Investigational New Drugs,volume 28,issue 4 , Vol. 28, Iss. 4, 2010-08 , pp. 381-391

Springer Publishing Company

Abstract Access to resources Recommend Favorite

MER1, a novel organic arsenic derivative, has potent PML-RARα- independent cytotoxic activity against leukemia cells

By Golemovic Mirna,Quintás-Cardama Alfonso,Manshouri Taghi,Orsolic Nada,Duzkale Hatice,Johansen Mary,Freireich Emil,Kantarjian Hagop,Zingaro Ralph,Verstovsek Srdan in (2010)

Investigational New Drugs,volume 28,issue 4 , Vol. 28, Iss. 4, 2010-08 , pp. 402-412

Springer Publishing Company

Abstract Access to resources Recommend Favorite

The effect of cellular environment and p53 status on the mode of action of the platinum derivative LA-12

By Roubalová Eva,Kvardová Veronika,Hrstka Roman,Bořilová Šárka,Michalová Eva,Dubská Lenka,Müller Petr,Sova Petr,Vojtěšek Bořivoj in (2010)

Investigational New Drugs,volume 28,issue 4 , Vol. 28, Iss. 4, 2010-08 , pp. 445-453

Springer Publishing Company

Abstract Access to resources Recommend Favorite